The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Goyal, Ashish ^a   Murray, John M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VACCINE; HEPATITIS VACCINE; INTERFERON; PRENYLATION INHIBITOR; UNCLASSIFIED DRUG; ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE TRANSMISSION; ENDEMIC DISEASE; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HEPATITIS DELTA VIRUS; HUMAN; MATHEMATICAL MODEL; METHODOLOGY; NEWBORN; PERINATAL INFECTION; PREVALENCE; SENSITIVITY ANALYSIS; VACCINATION; VERTICAL TRANSMISSION; VIRUS INFECTIVITY; ADOLESCENT; ADULT; HEPATITIS B, CHRONIC; HEPATITIS D, CHRONIC; INFANT; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; DISEASE TRANSMISSION, INFECTIOUS; HEPATITIS B, CHRONIC; HEPATITIS D, CHRONIC; HUMANS; INFANT; INFANT, NEWBORN; PREVALENCE; VACCINATION; YOUNG ADULT;

EID: 84907966521     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110143     Document Type: Article

References (45)

1. Lavanchy D (2005) Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 34 Suppl 1: S1-3.
2. Lavanchy D (2004) Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11: 97-107.
3. Fitzsimons D, Francois G, Hall A, McMahon B, Meheus A, et al. (2005) Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 23: 4158-4166.
4. Perz JF, Elm JL, Jr., Fiore AE, Huggler JI, Kuhnert WL, et al. (2006) Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination. Pediatrics 118: 1403-1408.
5. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156.
6. Abbas Z, Jafri W, Raza S (2010) Hepatitis D: Scenario in the Asia-Pacific region. World J Gastroenterol 16: 554-562.
7. Bonino F, Rizzetto M (1989) Hepatitis Delta Virus in Acute and Chronic Liver Disease. In: Gitnick G, editor. Modern Concepts of Acute and Chronic Hepatitis: Springer US. pp. 113-126.
8. Buti M, Homs M, Rodriguez-Frias F, Funalleras G, Jardi R, et al. (2011) Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study. J Viral Hepat 18: 434-442.
9. Purcell RH, Gerin JL (1996) Hepatitis Delta virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven. pp. 2819-2829.
10. Wedemeyer H, Manns MP (2010) Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol 7: 31-40.
11. Rizzetto M, Ciancio A (2012) Epidemiology of hepatitis D. Semin Liver Dis 32: 211-219.
12. Niro GAF, Rosanna; Ippolito, Antonio Massimo; Andriulli, Angelo (2012) Epidemiology and diagnosis of hepatitis D virus. Future Virology 7: 709-717.
13. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14: 4300-4308.
14. Alter MJ (2003) Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 39 Suppl 1: S64-69.
15. Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, et al. (2003) Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology 125: 444-451.
16. Xiridou M, Borkent-Raven B, Hulshof J, Wallinga J (2009) How hepatitis D virus can hinder the control of hepatitis B virus. PLoS One 4: e5247.
17. Polish LB, Gallagher M, Fields HA, Hadler SC (1993) Delta hepatitis: molecular biology and clinical and epidemiological features. Clin Microbiol Rev 6: 211-229.
18. Lai MM (1995) The molecular biology of hepatitis delta virus. Annu Rev Biochem 64: 259-286.
19. Zhao S, Xu Z, Lu Y (2000) A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol 29: 744-752.
20. Medley GF, Lindop NA, Edmunds WJ, Nokes DJ (2001) Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control. Nat Med 7: 619-624.
21. Pang J, Cui JA, Zhou X (2010) Dynamical behavior of a hepatitis B virus transmission model with vaccination. J Theor Biol 265: 572-578.
22. Zou L, Zhang W, Ruan S (2010) Modeling the transmission dynamics and control of hepatitis B virus in China. J Theor Biol 262: 330-338.
23. Edmunds WJ, Medley GF, Nokes DJ (1996) Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses. Trans R Soc Trop Med Hyg 90: 436-440.
24. Elgouhari HM, Abu-Rajab Tamimi TI, Carey WD (2008) Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis. Cleve Clin J Med 75: 881-889.
25. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination. Vaccine 27: 6550-6557.
26. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, et al. (2002) Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol 97: 2886-2895.
27. Fattovich G (2003) Natural history of hepatitis B. J Hepatol 39 Suppl 1: S50-58.
28. Fattovich G (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23: 47-58.
29. Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, et al. (2002) Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 34: 569-572.
30. Fung SK, Lok AS (2004) Treatment of chronic hepatitis B: who to treat, what to use, and for how long? Clin Gastroenterol Hepatol 2: 839-848.
31. World Health Organization (2001) Hepatitis D.
32. MOHC (2013) Ministry of Health of the People's Republic of China.
33. Yang SG, Wang B, Chen P, Yu CB, Deng M, et al. (2012) Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation. PLoS One 7: e47808.
34. Lu J, Zhou Y, Lin X, Jiang Y, Tian R, et al. (2009) General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007. PLoS One 4: e8467.
35. Lutgehetmann M, Mancke LV, Volz T, Helbig M, Allweiss L, et al. (2012) Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Hepatology 55: 685-694.
36. Niro GA, Rosina F, Rizzetto M (2005) Treatment of hepatitis D. J Viral Hepat 12: 2-9.
37. Bordier BB, Ohkanda J, Liu P, Lee SY, Salazar FH, et al. (2003) In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest 112: 407-414.
38. Bordier BB, Marion PL, Ohashi K, Kay MA, Greenberg HB, et al. (2002) A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J Virol 76: 10465-10472.
39. Bordier BB, Glenn JS (2004) Testing antivirals against hepatitis delta virus: farnesyl transferase inhibitors. Methods Mol Med 96: 539-553.
40. Shen L, Gu Y, Sun L, Yang Y, Wang F, et al. (2012) Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China. J Med Virol 84: 445-449.
41. Chen P, Yu C, Ruan B, Yang S, Ren J, et al. (2013) Prevalence of hepatitis B in insular regions of southeast China: a community-based study. PLoS One 8: e56444.
42. The World Bank (2013) Pregnant women receiving prenatal care. The World Bank.
43. Kao JH, Chen PJ, Lai MY, Chen DS (2002) Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes. J Clin Microbiol 40: 3047-3049.
44. BUREAU OF DEMOCRACY HR, AND LABOR (2010) 2009 Human Rights Report: China (includes Tibet, Hong Kong, and Macau).
45. UNICEF (2013) China-Statistics. unicef.